Literature DB >> 23868567

Phrenic nerve stimulation in CRT patients and benefits of electronic lead repositioning: the ERACE trial.

Stephan Goetze1, Pascal Defaye, Alexander Bauer, Matthias Merkel, Olivier Bizeau, Sven Treusch, Klaus Contzen, Claus Juenger, Joachim Winter.   

Abstract

PURPOSE: Despite novel left ventricular (LV) lead technologies, phrenic nerve stimulation (PNS) remains an adverse effect observed in many patients with cardiac resynchronization therapy (CRT). Beyond anatomic repositioning, modern CRT devices allow avoidance of PNS also by software-based adaption of the pacing configuration. The Electronic Repositioning With Acuity and Easytrak Leads study evaluated the incidence of PNS in a CRT population and examined how often LV lead relocation can be avoided by "electronic repositioning" (ER).
METHODS: Patients who had an indication for implantation of a first CRT defibrillator with the option of ER were enrolled. Primary endpoint was the efficiency of ER determined by the frequency of PNS with the standard pacing configuration (LV tip to RV coil) avoidable by ER. PNS and pacing parameters were evaluated during implant, predischarge, and first routine follow-up (FU) using four different pacing configurations available by ER.
RESULTS: In total, 292 patients were enrolled and provided with a transvenous LV lead (82.2 % male, 65.5 ± 9.2 years old). The majority of the population was in NYHA III (84.2 %) with a LV ejection fraction of 25.3 ± 6.8 % and mean QRS width of 155 ± 27 ms, ischemic cardiomyopathy was present in 43.6 %. Median FU was 116 days. In the standard pacing configuration, PNS was inducible in 19.0/25.6/24.6 % at implant/predischarge/FU, respectively, resulting in 32.2 % of the patients presenting at least once with PNS. The safety margin for the standard pacing configuration between LV and PNS threshold was <1.0 V at 0.5 ms in 5.6/7.0/5.0 % of the patients, corresponding with a total rate of 11.6 % during the FU. In the finally chosen configuration, clinically relevant PNS occurred in 1.0/2.2/1.3 %. The four vector configurations allowed all but 6 of 292 (2 %) patients to be reprogrammed using ER without reoperation.
CONCLUSIONS: The incidence of inducible PNS in CRT patients is considerable. In this study, PNS could be avoided in the majority of the patients by means of electronic repositioning. Thus, the use of ER should be considered for CRT patients.

Entities:  

Mesh:

Year:  2013        PMID: 23868567     DOI: 10.1007/s10840-013-9811-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  24 in total

1.  Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects.

Authors:  C Alonso; C Leclercq; F R d'Allonnes; D Pavin; F Victor; P Mabo; J C Daubert
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation.

Authors:  Jean Champagne; Jeffrey S Healey; Andrew D Krahn; Francois Philippon; Osnat Gurevitz; Anne Swearingen; Michael Glikson
Journal:  Europace       Date:  2011-01-26       Impact factor: 5.214

3.  2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Authors:  Kenneth Dickstein; Panos E Vardas; Angelo Auricchio; Jean-Claude Daubert; Cecilia Linde; John McMurray; Piotr Ponikowski; Silvia Giuliana Priori; Richard Sutton; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

4.  Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study.

Authors:  Norbert Klein; Maika Klein; Heinrich Weglage; Oliver Przibille; Sven Fischer; Hans-Joachim Trappe; Frank Birkenhauer; Dietrich Pfeiffer
Journal:  Europace       Date:  2012-01-25       Impact factor: 5.214

5.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.

Authors:  Angel R León; William T Abraham; Anne B Curtis; James P Daubert; Westby G Fisher; John Gurley; David L Hayes; Randy Lieberman; Susan Petersen-Stejskal; Kevin Wheelan
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

6.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

7.  Short-spaced dipole for managing phrenic nerve stimulation in patients with CRT: the "phrenic nerve mapping and stimulation EP" catheter study.

Authors:  Mauro Biffi; Francesco Zanon; Emanuele Bertaglia; Luigi Padeletti; Annamaria Varbaro; Tiziana De Santo; Giuseppe Boriani; Zhongping Yang
Journal:  Heart Rhythm       Date:  2012-09-01       Impact factor: 6.343

8.  Beyond coronary sinus angiography: the value of coronary arteriography and identification of the pericardiophrenic vein during left ventricular lead placement.

Authors:  Marmar Vaseghi; David A Cesario; Sen Ji; Kevin M Shannon; Isaac Wiener; Noel G Boyle; Gregg C Fonarow; Miguel Valderrábano; Kalyanam Shivkumar
Journal:  Pacing Clin Electrophysiol       Date:  2005-03       Impact factor: 1.976

9.  Long-term retention of cardiac resynchronization therapy.

Authors:  Bradley P Knight; Aseem Desai; James Coman; Mitchell Faddis; Patrick Yong
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

10.  Quadripolar Left Ventricular Lead in a Patient with CRT-D Does Not Overcome Phrenic Nerve Stimulation.

Authors:  Mariana S Parahuleva; Ritvan Chasan; Nedim Soydan; Yasser Abdallah; Christiane Neuhof; Harald Tillmanns; Ali Erdogan
Journal:  Clin Med Insights Cardiol       Date:  2011-04-27
View more
  3 in total

Review 1.  Phrenic nerve stimulation in cardiac resynchronization therapy.

Authors:  Ghassan Moubarak; Abdeslam Bouzeman; Jacky Ollitrault; Frederic Anselme; Serge Cazeau
Journal:  J Interv Card Electrophysiol       Date:  2014-06-17       Impact factor: 1.900

Review 2.  An Overview of Current Cardiac Resynchronization Therapy.

Authors:  Chien-Ming Cheng; Jin-Long Huang; Tsu-Juey Wu; Yu-Cheng Hsieh; Kuo-Yang Wang; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

3.  Percutaneous Epicardial Pacing using a Novel Insulated Multi-electrode Lead.

Authors:  Faisal F Syed; Christopher V DeSimone; Elisa Ebrille; Prakriti Gaba; Dorothy J Ladewig; Susan B Mikell; Scott H Suddendorf; Emily J Gilles; Andrew J Danielsen; Markéta Lukášová; Jiří Wolf; Pavel Leinveber; Miroslav Novák; Zdeněk Stárek; Tomas Kara; Charles J Bruce; Paul A Friedman; Samuel J Asirvatham
Journal:  JACC Clin Electrophysiol       Date:  2015-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.